Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery

NCT00967447 · clinicaltrials.gov ↗

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Thromboembolism
Arthroplasty, Replacement, Hip

Sponsor

Boehringer Ingelheim